DEXCOM, INC. (DXCM) FY2026 Q2 P&L / Income Statement

DEXCOM, INC. (DXCM) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Contract with Customer, Sales Channel. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue

1,308,400,000 US dollars

Cost of sales

478,400,000 US dollars

Gross profit

830,000,000 US dollars

Total operating expenses

511,700,000 US dollars

Operating income

318,300,000 US dollars

Other income (expense), net (calculated)

negative 800,000 US dollars

Income before income taxes

317,500,000 US dollars

Income tax expense

68,400,000 US dollars

Net income

249,100,000 US dollars

Distributor

1,102,400,000 US dollars

Direct

206,000,000 US dollars

Selling, general and administrative

358,700,000 US dollars

Research and development

153,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.